Title |
mcr-1 and blaKPC-3 in Escherichia coli Sequence Type 744 after Meropenem and Colistin Therapy, Portugal - Volume 23, Number 8—August 2017 - Emerging Infectious Diseases journal - CDC
|
---|---|
Published in |
Emerging Infectious Diseases, August 2017
|
DOI | 10.3201/eid2308.170162 |
Pubmed ID | |
Authors |
Marta Tacão, Rafael dos Santos Tavares, Pedro Teixeira, Inês Roxo, Elmano Ramalheira, Sónia Ferreira, Isabel Henriques |
Abstract |
Escherichia coli Ec36 was recovered from a patient in Portugal after treatment with meropenem and colistin. Besides an IncF plasmid with Tn1441d-blaKPC-3, already reported in clinical strains in this country, E. coli Ec36 co-harbored an IncX4::mcr-1 gene. Results highlight emerging co-resistance to carbapenems and polymyxins after therapy with drugs from both classes. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 67% |
Australia | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 58 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 11 | 19% |
Student > Ph. D. Student | 9 | 16% |
Researcher | 8 | 14% |
Student > Bachelor | 7 | 12% |
Other | 4 | 7% |
Other | 7 | 12% |
Unknown | 12 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 12 | 21% |
Biochemistry, Genetics and Molecular Biology | 9 | 16% |
Medicine and Dentistry | 9 | 16% |
Immunology and Microbiology | 5 | 9% |
Veterinary Science and Veterinary Medicine | 3 | 5% |
Other | 5 | 9% |
Unknown | 15 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 July 2017.
All research outputs
#2,884,247
of 23,978,283 outputs
Outputs from Emerging Infectious Diseases
#2,874
of 9,336 outputs
Outputs of similar age
#53,496
of 319,889 outputs
Outputs of similar age from Emerging Infectious Diseases
#54
of 117 outputs
Altmetric has tracked 23,978,283 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,336 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 44.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 319,889 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 117 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.